| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/08/2004 | CA2490079A1 Purified amylase inhibitor and novel process for obtaining the same |
| 01/08/2004 | CA2489660A1 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/08/2004 | CA2489552A1 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 01/08/2004 | CA2488703A1 Food and beverage product for stimulating gastrointestinal mobility |
| 01/08/2004 | CA2488566A1 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 01/08/2004 | CA2488526A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | CA2482161A1 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 01/08/2004 | CA2481890A1 Synergistic interaction of abacavir and alovudine |
| 01/08/2004 | CA2472438A1 Mannose binding protein for use in anti-hiv treatment |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1378572A1 Bmp-11 compositions |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378522A2 Methods of enhancing bioactivity of chemokines |
| 01/07/2004 | EP1378510A1 Triazaspiro 5.5]undecane derivatives and drugs containing the same as the active ingredient |
| 01/07/2004 | EP1378509A1 Drugs containing triazaspiro 5.5]undecane derivatives as the active ingredient |
| 01/07/2004 | EP1378507A2 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same |
| 01/07/2004 | EP1378247A1 Visual function improving agents |
| 01/07/2004 | EP1378246A1 Remedies for arteriosclerosis |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377671A2 Oncolytic adenoviral vectors |
| 01/07/2004 | EP1377663A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 01/07/2004 | EP1377610A2 Osteoprotegerin in milk |
| 01/07/2004 | EP1377607A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 01/07/2004 | EP1377590A1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377587A1 Protein phosphate inhibitors |
| 01/07/2004 | EP1377586A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377584A1 Novel cyclohexenyl phenyl diazepines as vasopressin and oxytocin receptor modulators |
| 01/07/2004 | EP1377583A1 Novel tricyclic hydroxy carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377580A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 01/07/2004 | EP1377579A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377571A1 Compounds for use in the treatment of skin conditions |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377565A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 01/07/2004 | EP1377560A1 Piperazine derivatives as tachykinin antagonists |
| 01/07/2004 | EP1377558A1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists |
| 01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377553A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | EP1377545A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae |
| 01/07/2004 | EP1377542A1 Hiv protease inhibitors based on amino acid derivatives |
| 01/07/2004 | EP1377319A2 Fusion proteins |
| 01/07/2004 | EP1377318A2 Pregabalin lactose conjugates |
| 01/07/2004 | EP1377313A1 Enzymes combination coadjuvating in the interferon therapy |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377302A1 Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377294A2 Use of neuroactive substances for the treatment of parkinsons disease and pharmaceutical combination |
| 01/07/2004 | EP1377293A1 Aryl and biaryl piperidines used as mch antagonists |
| 01/07/2004 | EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | EP1377288A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 01/07/2004 | EP1377284A1 Controlled release arginine formulations |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/07/2004 | EP1377282A2 Aryl-n-cyanoguanidines and methods related thereto |
| 01/07/2004 | EP1377280A2 Bulking agents as satiety agents |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377273A2 Method for producing an active ingredient concentrate, and an active ingredient concentrate |
| 01/07/2004 | EP1082119B1 Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 01/07/2004 | EP1056733B1 Histamine h3 receptor ligands |
| 01/07/2004 | EP1019082B1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/07/2004 | EP0944611B1 Dimesylate salts of neuropeptide y ligands |
| 01/07/2004 | EP0943334B1 Tortoise oil, turtle oil, compositions containing them, their preparation processes and uses |
| 01/07/2004 | EP0931092B1 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 01/07/2004 | EP0909132B1 Dietetic baby food formula containing conjugated linoleic acids |
| 01/07/2004 | EP0719152B1 Novel therapeutic and dietetic uses of a brain phospholipid-based complex |
| 01/07/2004 | EP0661992B1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466680A Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 01/07/2004 | CN1466591A Nucleoside derivatives |
| 01/07/2004 | CN1466590A Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| 01/07/2004 | CN1466586A Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 01/07/2004 | CN1466580A Thiazole or oxazole derivatives |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1466575A Quinolene derivatives as anti-inflammation agents |
| 01/07/2004 | CN1466465A Preventives or remedies for obesity or fatty liver |
| 01/07/2004 | CN1466459A 营养组合物 The nutritional composition |
| 01/07/2004 | CN1466458A Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration |
| 01/07/2004 | CN1465594A Mouse interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465593A Mouse interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465592A Human Interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465368A Black boned chicken active capsule and preparation process thereof |
| 01/07/2004 | CN1465338A Skin activating composition for external used anti-aging preparation |
| 01/07/2004 | CN1133743C Modified clotting Factor VII |
| 01/07/2004 | CN1133650C A method of identifying CFTP-binding compounds useful for activating chloride conductance in animal cells |
| 01/07/2004 | CN1133648C Substituted phenylalamine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/07/2004 | CN1133647C Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 01/07/2004 | CN1133636C Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 01/07/2004 | CN1133635C Cyanopyrroles as progesterone receptor agonists |
| 01/07/2004 | CN1133634C Heterocyclic derivatives which inhibit factor Xa |
| 01/07/2004 | CN1133625C Quinazoline derivatives |
| 01/07/2004 | CN1133623C Process for producing optically active imidazole compound, intermediates for synthesizing samke and mfg method |
| 01/07/2004 | CN1133622C Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/07/2004 | CN1133621C Cyclohexanediole derivatives |
| 01/07/2004 | CN1133464C Pharmaceutical compositions for controlled release of soluble receptors |
| 01/07/2004 | CN1133462C Methods and compositions for healing and repair of connective tissue attachment |
| 01/07/2004 | CN1133429C Use of macrolide compounds for treatment of ARDS |